A. Del Bufalo

553 total citations
12 papers, 413 citations indexed

About

A. Del Bufalo is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, A. Del Bufalo has authored 12 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pharmacology and 3 papers in Organic Chemistry. Recurrent topics in A. Del Bufalo's work include Cholinesterase and Neurodegenerative Diseases (5 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Receptor Mechanisms and Signaling (2 papers). A. Del Bufalo is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (5 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Receptor Mechanisms and Signaling (2 papers). A. Del Bufalo collaborates with scholars based in Italy, Switzerland and Mexico. A. Del Bufalo's co-authors include Patrizia Russo, Alfredo Cesario, Alessandra Frustaci, Milena Fini, Massimo Fini, Mirta Milić, Stefano Bonassi, Rafael Valencia‐Quintana, Juana Sánchez-Alarcón and Tiziano Moccetti and has published in prestigious journals such as Current Medicinal Chemistry, Mutation research. Fundamental and molecular mechanisms of mutagenesis and Current Pharmaceutical Design.

In The Last Decade

A. Del Bufalo

12 papers receiving 401 citations

Peers

A. Del Bufalo
Vicky Ping Chen United States
A. Del Bufalo
Citations per year, relative to A. Del Bufalo A. Del Bufalo (= 1×) peers Vicky Ping Chen

Countries citing papers authored by A. Del Bufalo

Since Specialization
Citations

This map shows the geographic impact of A. Del Bufalo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Del Bufalo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Del Bufalo more than expected).

Fields of papers citing papers by A. Del Bufalo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Del Bufalo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Del Bufalo. The network helps show where A. Del Bufalo may publish in the future.

Co-authorship network of co-authors of A. Del Bufalo

This figure shows the co-authorship network connecting the top 25 collaborators of A. Del Bufalo. A scholar is included among the top collaborators of A. Del Bufalo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Del Bufalo. A. Del Bufalo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Russo, Patrizia & A. Del Bufalo. (2015). Conopeptides in Addiction Disorders Treatment. International journal of advanced research in chemical sciences. 2(7). 37–42. 1 indexed citations
2.
Lococo, Filippo, Alfredo Cesario, A. Del Bufalo, et al.. (2015). Novel Therapeutic Strategy in the Management of COPD: A Systems Medicine Approach. Current Medicinal Chemistry. 22(32). 3655–3675. 11 indexed citations
3.
Russo, Patrizia, A. Del Bufalo, & Massimo Fini. (2015). Deep sea as a source of novel-anticancer drugs: update on discovery and preclinical/clinical evaluation in a systems medicine perspective. PubMed. 14. 228–36. 29 indexed citations
4.
Bufalo, A. Del, et al.. (2014). Alpha9Alpha10 Nicotinic Acetylcholine Receptors as Target for the Treatment of Chronic Pain. Current Pharmaceutical Design. 20(38). 6042–6047. 27 indexed citations
5.
Milić, Mirta, Alessandra Frustaci, A. Del Bufalo, et al.. (2014). DNA damage in non-communicable diseases: A clinical and epidemiological perspective. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 776. 118–127. 47 indexed citations
6.
Russo, Patrizia, A. Del Bufalo, Alessandra Frustaci, Massimo Fini, & Alfredo Cesario. (2014). Beyond Acetylcholinesterase Inhibitors for Treating Alzheimer&aposs Disease: .α7-nAChR Agonists in Human Clinical Trials. Current Pharmaceutical Design. 20(38). 6014–6021. 22 indexed citations
7.
Russo, Patrizia, et al.. (2014). Cholinergic Receptors as Target for Cancer Therapy in a Systems Medicine Perspective. Current Molecular Medicine. 14(9). 1126–1138. 41 indexed citations
8.
Russo, Patrizia, Alessandra Frustaci, A. Del Bufalo, Milena Fini, & Alfredo Cesario. (2013). Multitarget Drugs of Plants Origin Acting on Alzheimer's Disease. Current Medicinal Chemistry. 20(13). 1686–1693. 67 indexed citations
9.
Russo, Patrizia, Alessandra Frustaci, A. Del Bufalo, Milena Fini, & Alfredo Cesario. (2013). From Traditional European Medicine to Discovery of New Drug Candidates for the Treatment of Dementia and Alzheimer's Disease: Acetylcholinesterase Inhibitors. Current Medicinal Chemistry. 20(8). 976–983. 29 indexed citations
10.
Filippini, Perla, Nicoletta Del Papa, Domenico Sambataro, et al.. (2012). Emerging Concepts on Inhibitors of Indoleamine 2,3-Dioxygenase in Rheumatic Diseases. Current Medicinal Chemistry. 19(31). 5381–5393. 22 indexed citations
11.
Russo, Patrizia, A. Del Bufalo, & Alfredo Cesario. (2012). Flavonoids Acting on DNA Topoisomerases: Recent Advances and Future Perspectives in Cancer Therapy. Current Medicinal Chemistry. 19(31). 5287–5293. 49 indexed citations
12.
Tonstad, Serena, D Pometta, D.W. Erkelens, et al.. (1994). The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. European Journal of Clinical Pharmacology. 46(5). 405–410. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026